| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 281,524 | 301,512 | 304,030 | 325,985 | | Cost of Revenue | 194,609 | 213,049 | 218,842 | 235,852 | | | Gross Profit | 86,915 | 88,463 | 85,188 | 90,133 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 42,565 | 44,981 | 48,515 | 51,108 | | Non Recurring | 703 | 6,628 | 2,270 | 2,387 | | Others | 15,664 | 13,808 | 14,062 | 13,384 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 27,983 | 23,046 | 20,341 | 23,254 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 911 | 1,719 | 1,569 | 103 | | Earnings Before Interest And Taxes | 28,894 | 24,765 | 21,910 | 23,357 | | Interest Expense | 466 | 1,320 | 843 | 2,089 | | Income Before Tax | 28,428 | 23,445 | 21,067 | 21,268 | | Income Tax Expense | 6,971 | 6,328 | 5,180 | 6,572 | | Minority Interest |
-
|
-
|
-
| (596) | | | | Net Income From Continuing Ops | 21,457 | 17,117 | 15,887 | 14,100 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 21,457 | 17,117 | 15,887 | 14,100 | | Preferred Stock And Other Adjustments | (935) | (987) | (824) |
-
| | | Net Income Applicable To Common Shares | $20,522 | $16,130 | $15,063 | $14,100 |
|
0.51% Nasdaq 
Income Statement
